OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
Orthofix Medical Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$9.59+0.21 (+2.24%)
Close on Oct 19, 2026
- Market cap
- $392.29M
- P/E (TTM)
- –
- Dividend yield
- –
Orthofix Medical Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Spine [Member] | $691.09M | $687.67M | $687.66M | $685.61M | $679.65M | $677.86M | $675.31M | $665.22M | $653.46M | $643.41M | $631.32M | $555.09M | 82.9% | +1.7% |
| Global Orthopedics [Member] | – | – | – | $132.45M | $129.38M | $126.67M | $124.18M | $119.03M | $118.19M | $116.64M | $115.32M | $113.37M | – | – |
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $682.01M | $683.71M | $684.07M | $682.98M | $679.28M | $674.48M | $672.82M | $660.50M | $647.11M | $634.76M | $620.83M | $549.57M | 81.9% | +0.4% |
| International [Member] | $151.18M | $141.66M | $138.25M | $135.07M | $129.75M | $130.05M | $126.68M | $123.75M | $124.54M | $125.29M | $125.81M | $118.89M | 18.1% | +16.5% |
| Others [Member] | $86.12M | $78.59M | $76.73M | $73.64M | $69.48M | $69.50M | $66.40M | $64.52M | $64.12M | $65.14M | $65.83M | – | 10.3% | +23.9% |
| Italy | $23.48M | $23.13M | $22.28M | $21.96M | $21.44M | $21.05M | $21.00M | $20.79M | $20.20M | $20.21M | $20.06M | – | 2.8% | +9.5% |
| United Kingdom | $14.75M | $14.17M | $13.33M | $12.79M | $12.08M | $11.59M | $11.18M | $10.85M | $10.84M | $10.76M | $10.91M | – | 1.8% | +22.0% |
| France | $12.05M | $11.97M | $11.96M | $12.86M | $13.17M | $13.49M | $13.39M | $11.91M | $11.85M | $11.15M | $11.10M | – | 1.4% | -8.5% |
| Germany | $9.12M | $9.07M | $9.11M | $9.13M | $8.98M | $9.11M | $9.00M | $9.50M | $10.61M | $10.93M | $11.47M | – | 1.1% | +1.6% |
| Brazil | $5.67M | $4.74M | $4.84M | $4.70M | $4.59M | $5.31M | $5.71M | $6.18M | $6.92M | $7.10M | $6.45M | – | 0.7% | +23.3% |
From the segment and revenue-disaggregation notes of Orthofix Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.